ISSN: 0300-7995
Journal Home
Journal Guideline
Current Medical Research and Opinion Q2 Unclaimed
Current Medical Research and Opinion is a journal indexed in SJR in Medicine (miscellaneous) with an H index of 121. It has a price of 4000 €. It has an SJR impact factor of 0,712 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,712.
Current Medical Research and Opinion focuses its scope in these topics and keywords: treatment, patients, observational, safety, randomized, delivery, efficacy, clinical, study, results, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -


4000 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,712
SJR Impact factor121
H Index193
Total Docs (Last Year)750
Total Docs (3 years)7365
Total Refs1702
Total Cites (3 years)678
Citable Docs (3 years)2.25
Cites/Doc (2 years)38.16
Ref/DocOther journals with similar parameters
Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2
Compare this journals
Aims and Scope
Best articles by citations
Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension
View moreFunctional, Cognitive and Behavioral Effects of Donepezil in Patients with Moderate Alzheimer's Disease
View moreThe impact of migraine on work, family, and leisure among young women -a multinational study
View moreClinical Implications of Dopamine Research in Schizophrenia
View moreEfficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study
View moreFocus on Amisulpride
View moreFocus on anastrozole and breast cancer
View moreUtilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome
View moreThe value of post-marketing medication surveys in Parkinson's disease
View moreThe effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol
View moreLow-density lipoprotein 4: a novel predictor of coronary artery disease severity
View moreThe Choice of Antihypertensive Drugs in Patients with Erectile Dysfunction
View moreDeleterious Effects of Increased Body Weight Associated with Intensive Insulin Therapy for Type 1 Diabetes: Increased Blood Pressure and Worsened Lipid Profile Partially Negate Improvements in Life Expectancy
View moreRandomized, double-blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort
View moreLong-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study
View moreDifferences in Lipid Profiles of Patients Given Rosiglitazone Followed by Pioglitazone
View moreLow Serum Levels of High-density Lipoprotein Cholesterol and Hypolipidaemic Treatment
View moreTreatment of Overactive Bladder with Once-daily Extended-release Tolterodine or Oxybutynin: The Antimuscarinic Clinical Effectiveness Trial (ACET)
View moreEfficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis
View moreWhat Impact Would Pancreatic Beta-cell Preservation Have on Life Expectancy, Quality-adjusted Life Expectancy and Costs of Complications in Patients with Type 2 Diabetes? A Projection Using the CORE Diabetes Model
View moreNo donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment
View moreNumber needed to treat and costs per responder among biologic treatments for moderate-to-severe psoriasis: a network meta-analysis
View moreA Comparison of Adverse Renovascular Experiences Among Osteoarthritis Patients Treated with Rofecoxib and Comparator Non-selective Non-steroidal Anti-inflammatory Agents
View morePatient and Physician Satisfaction with Aceclofenac: Results of the European Observational Cohort Study (Experience with Aceclofenac for Inflammatory Pain in Daily Practice)
View more
Comments